Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for VCEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
March 31, 2026 356.23M
December 31, 2025 354.64M
September 30, 2025 321.86M
June 30, 2025 306.81M
March 31, 2025 295.49M
December 31, 2024 291.97M
September 30, 2024 257.47M
June 30, 2024 242.98M
March 31, 2024 233.90M
December 31, 2023 225.95M
September 30, 2023 204.38M
June 30, 2023 198.93M
March 31, 2023 193.98M
December 31, 2022 192.27M
September 30, 2022 177.84M
June 30, 2022 174.82M
March 31, 2022 172.48M
December 31, 2021 170.46M
September 30, 2021 156.78M
June 30, 2021 151.09M
March 31, 2021 140.21M
December 31, 2020 134.26M
September 30, 2020 114.63M
June 30, 2020 107.60M
March 31, 2020 110.45M
Date Value
December 31, 2019 111.09M
September 30, 2019 96.99M
June 30, 2019 88.54M
March 31, 2019 103.06M
December 31, 2018 102.23M
September 30, 2018 94.48M
June 30, 2018 90.60M
March 31, 2018 20.94M
December 31, 2017 22.54M
September 30, 2017 16.74M
June 30, 2017 13.97M
March 31, 2017 15.50M
December 31, 2016 24.71M
September 30, 2016 11.39M
June 30, 2016 17.11M
March 31, 2016 19.23M
December 31, 2015 22.13M
September 30, 2015 26.41M
June 30, 2015 30.24M
March 31, 2015 31.70M
December 31, 2014 35.64M
September 30, 2014 37.78M
June 30, 2014 2.785M
March 31, 2014 3.769M
December 31, 2013 3.894M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Marker Therapeutics, Inc. 13.80M
Krystal Biotech, Inc. 1.277B
TG Therapeutics, Inc. 583.13M
Gyre Therapeutics, Inc. 101.31M
ACADIA Pharmaceuticals, Inc. 1.248B

Shareholders Equity (Quarterly) Related Metrics